Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MiR-21 attenuates apoptosis-triggered by amyloid-β via modulating PDCD4/ PI3K/AKT/GSK-3β pathway in SH-SY5Y cells
Mei-Guo Feng, Cuifang Liu, Li Chen, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 101, pp. 1003-1007
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

The role of microRNAs in neurodegenerative diseases: a review
Shijie Li, Zhixin Lei, Taolei Sun
Cell Biology and Toxicology (2022) Vol. 39, Iss. 1, pp. 53-83
Open Access | Times Cited: 75
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Renqing Zhao
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Neuron-derived exosomes with high miR-21-5p expression promoted polarization of M1 microglia in culture
Zhenyu Yin, Zhaoli Han, Tianpeng Hu, et al.
Brain Behavior and Immunity (2019) Vol. 83, pp. 270-282
Closed Access | Times Cited: 127
Amyloid Beta and MicroRNAs in Alzheimer’s Disease
Nnana Amakiri, Aaron Kubosumi, James Tran, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 94
MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders
Xue Bai, Zhigang Bian
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 45
Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials
Maryam Ghasemi, Elham Roshandel, Mozhdeh Mohammadian, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer’s disease and aging
Bidur Paudel, Si‐Yeon Jeong, Carolina Pena Martinez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk
Daichi Shigemizu, Risa Mitsumori, Shintaro Akiyama, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 51
Inverse Correlation Between Alzheimer’s Disease and Cancer: Short Overview
Agnieszka Zabłocka, Wioletta Kazana, Marta Sochocka, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 12, pp. 6335-6349
Open Access | Times Cited: 42
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities
Nermeen Z. Abuelezz, Fayza Eid Nasr, Mohammad A. Abdulkader, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 42
Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis
Yangfan Cheng, Xiaojing Gu, Tianmi Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 16
miR‑133b is a potential diagnostic biomarker for Alzheimer's disease and has a neuroprotective role
Qin Yang, Qiuling Zhao, Yanliang Yin
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 51
Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
Alex Cleber Improta‐Caria, Carolina Kymie Vasques Nonaka, Bruno Raphael Ribeiro Cavalcante, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4977-4977
Open Access | Times Cited: 49
Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models
Giovanna Cenini, Matthias Hebisch, Vira Iefremova, et al.
Molecular and Cellular Neuroscience (2020) Vol. 110, pp. 103568-103568
Closed Access | Times Cited: 42
Programmed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer
Kaikai Lu, Qian Chen, Mengda Li, et al.
Free Radical Biology and Medicine (2020) Vol. 159, pp. 150-163
Closed Access | Times Cited: 39
Human urine-derived stem cell-derived exosomal miR-21-5p promotes neurogenesis to attenuate Rett syndrome via the EPha4/TEK axis
Wei Pan, Xiaoheng Xu, Meng Zhang, et al.
Laboratory Investigation (2021) Vol. 101, Iss. 7, pp. 824-836
Open Access | Times Cited: 38
Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer’s Disease
Mohamed J. Saadh, Faris Anad Muhammad, Tuqa S. Alazzawi, et al.
Molecular Neurobiology (2025)
Closed Access
miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells
Nan Zhang, Weiwei Li, Chunmei Lv, et al.
Neuroreport (2019) Vol. 31, Iss. 3, pp. 205-212
Closed Access | Times Cited: 39
Emerging Role of miR-21-5p in Neuron–Glia Dysregulation and Exosome Transfer Using Multiple Models of Alzheimer’s Disease
Gonçalo Garcia, Sara Pinto, Sofia Ferreira, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3377-3377
Open Access | Times Cited: 22
MicroRNA-21 Promotes the Viability, Proliferation and Milk Fat Synthesis of Ovine Mammary Epithelial Cells by Targeting PDCD4
Liyan Hu, Jiqing Wang, Zhiyun Hao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1460-1460
Open Access
Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management
Wang Dui, Zhao Xiao-bin, Zhang Haifeng, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation
Shama Rao, Leelavathi N. Madhu, Roshni Sara Babu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Circulating microRNAs as novel biomarkers of Alzheimer's disease
Mustapha Zendjabil
Clinica Chimica Acta (2018) Vol. 484, pp. 99-104
Closed Access | Times Cited: 32
MicroRNA miR-212 regulates PDCD4 to attenuate Aβ25–35-induced neurotoxicity via PI3K/AKT signaling pathway in Alzheimer’s disease
Yanjun Wang, Qing Chang
Biotechnology Letters (2020) Vol. 42, Iss. 9, pp. 1789-1797
Closed Access | Times Cited: 30
Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs
Marissa Alvarez, Erick Trent, Bruno de Souza Gonçalves, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top